Skip to Content

Join the 'Glaucoma (Open Angle)' group to help and get support from people like you.

Glaucoma (Open Angle) News

Generic Eye Drops for Seniors Could Save Millions of Dollars a Year

Posted 28 Jul 2017 by Drugs.com

FRIDAY, July 28, 2017 – Prescribing generic drugs for seniors' eye problems could save the U.S. government hundreds of millions of dollars a year, a new study suggests. Conditions like glaucoma and dry eye that require daily eye drops are common in old age. University of Michigan researchers report that eye doctors caring for seniors prescribe brand-name medications in more than three-quarters of cases, compared to one-third of cases among nearly all other specialties. "Lawmakers are currently looking for ways to reduce federal spending for health care, and policies that favor generics over brand medications or allow Medicare to negotiate drug prices may lead to cost savings," said study senior author Lindsey De Lott, of the university's Kellogg Eye Center. "Using a brand medication for a single patient may not seem like a big deal, but ultimately, these higher costs are paid by all of ... Read more

Related support groups: Eye Conditions, Glaucoma, Eye Dryness/Redness, Cataract, Glaucoma (Open Angle), Lumigan, Latanoprost, Xalatan, Travatan, Combigan, Alphagan, Travatan Z, Systane, Cosopt, Azopt, Soothe, Dorzolamide, Refresh, Dry Eye Disease, Brimonidine

Health Tip: Applying Eye Drops

Posted 9 May 2017 by Drugs.com

-- Applying eye drops without the excess trickling down your face can be tricky. The American Academy of Allergy Asthma and Immunology suggests: Wash your hands, then take the bottle of eye drops and slowly rotate it for 30 seconds. Lean your head back and gently pull down the lower eyelid. Use your index finger to pull down the lid, or use your thumb and index finger to gently pinch the lower lid. Taking care to avoid the dropper touching your eye, let one drop fall into the pocket formed in your lower eyelid. If you are supposed to use more than one drop, wait three to four minutes before applying the second one. Close your eyes for a minute, then put gentle pressure over the spot where your eyelid joins with your nose. Replace the cap on the bottle. Use a tissue to wipe away any extra medicine, and wash your hands again. Read more

Related support groups: Eye Conditions, Glaucoma, Eye Dryness/Redness, Cataract, Glaucoma (Open Angle), Conjunctivitis, Conjunctivitis - Bacterial, Dry Eye Disease, Glaucoma/Intraocular Hypertension, Conjunctivitis - Allergic, Seasonal Allergic Conjunctivitis, Inclusion Conjunctivitis, Glaucoma (Narrow Angle), Ocular Fungal Infection, Neonatal Conjunctivitis, Glaucoma with Pupillary Block

For Seniors, Treatment for One Eye Disease May Cause Another

Posted 16 Mar 2017 by Drugs.com

THURSDAY, March 16, 2017 – Drugs that preserve vision in people with the eye disease called age-related macular degeneration might increase the risk of another eye condition – glaucoma, a new study suggests. People who received at least seven eye injections of the drug bevacizumab (Avastin) each year to treat macular degeneration have a higher risk of eventually needing surgery to treat glaucoma, the Canadian study found. But, the researchers aren't suggesting that people forgo these treatments for macular degeneration. These drugs help stave off a previously untreatable cause of blindness in the elderly, and should continue to be used, the researchers said. And, if glaucoma does develop, treatments are available. "Even though there may be a risk here, this doesn't mean you should not be getting injections for macular degeneration," said study lead author Dr. Brennan Eadie. He's an ... Read more

Related support groups: Eye Conditions, Glaucoma, Macular Degeneration, Glaucoma (Open Angle), Votrient, Avastin, Sutent, Nexavar, Pazopanib, Stivarga, Sunitinib, Retinal Disorders, Glaucoma/Intraocular Hypertension, Sorafenib, Cyramza, Retinopathy, Bevacizumab, Inlyta, Ramucirumab, Cabometyx

U.S. Glaucoma Cases Expected to Surge by 2030

Posted 6 Jan 2017 by Drugs.com

FRIDAY, Jan. 6, 2017 – Glaucoma affects more than 3 million Americans, but that number is expected to surge to more than 4 million by 2030, eye experts say. Glaucoma is a group of incurable eye diseases that gradually lead to vision loss. There are two main types of glaucoma, but the most common form, which typically affects older people, causes an increase in pressure inside the eye that damages the optic nerve, according to the Glaucoma Research Foundation. Glaucoma is the No. 1 cause of preventable blindness, but the condition often develops without warning, the foundation said. Medication or surgery can help slow or prevent vision loss, but many people with glaucoma aren't even aware they have it. In many cases, the condition isn't detected until people lose side – or peripheral – vision. Eventually, glaucoma may cause people to permanently lose up to 40 percent of their vision, ... Read more

Related support groups: Diabetes, Type 2, Glaucoma, Diabetes, Type 1, Glaucoma (Open Angle), Pre-Diabetes, Diabetes Mellitus, Glaucoma/Intraocular Hypertension, Abnormal Glucose Tolerance, Glaucoma (Narrow Angle), Visual Defect/Disturbance, Glaucoma with Pupillary Block

Contacts May One Day Be Used to Deliver Glaucoma Medication

Posted 30 Aug 2016 by Drugs.com

TUESDAY, Aug. 30, 2016 – A special type of contact lens has been designed to gradually deliver medication to the eye, researchers report. This kind of contact lens could help people who have a hard time using eye drops to treat conditions such as glaucoma, the study authors explained. The new study showed that the drug-dispensing lenses were able to effectively lower the eye pressure in monkeys with glaucoma at least as much as the standard eye drops used to treat the disease. "This promising delivery system removes the burden of administration from the patient and ensures consistent delivery of medication to the eye, eliminating the ongoing concern of patient compliance with dosing," study co-author Dr. Janet Serle said in a news release from the Massachusetts Eye and Ear Infirmary. Serle is a glaucoma specialist at Icahn School of Medicine at Mount Sinai in New York City. Glaucoma is ... Read more

Related support groups: Eye Conditions, Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Blindness Biggest Fear for Many Americans

Posted 4 Aug 2016 by Drugs.com

THURSDAY, Aug. 4, 2016 – Blindness is what many Americans fear most, a new survey shows. "These findings underscore the importance of good eyesight to most and that having good vision is key to one's overall sense of well-being," said lead researcher Dr. Adrienne Scott and colleagues. Scott is an assistant professor of opthalmology at Johns Hopkins University School of Medicine in Baltimore. "The consistency of these findings among the varying ethnic/racial groups underscores the importance of educating the public on eye health and mobilizing public support for vision research," the researchers added in a news release. The nationwide online poll, commissioned by the nonprofit health research group known as Research!America, found that 88 percent of more than 2,000 respondents considered good vision vital to overall health. And 47 percent said losing their sight would have the most ... Read more

Related support groups: Eye Conditions, Smoking, Smoking Cessation, Glaucoma, Cataract, Macular Degeneration, Glaucoma (Open Angle), Retinal Disorders, Visual Defect/Disturbance, Glaucoma (Narrow Angle), Refraction - Assessment, Color Vision Defect (Acquired), Glaucoma with Pupillary Block

Routine Eye Exams See Vision Problems You Miss

Posted 14 Jul 2016 by Drugs.com

WEDNESDAY, July 13, 2016 – Routine eye checkups often pick up unnoticed problems, particularly in older adults, a new study says. "In asymptomatic patients, comprehensive routine optometric eye examinations detect a significant number of new eye conditions and/or results in management changes," said the study's author, Elizabeth Irving, and her colleagues from the University of Waterloo in Ontario, Canada. More than half of people with no new symptoms or vision problems receive new prescriptions or treatment changes as a result of routine eye exams, the researchers found. The need for vision prescription changes was found for two out of five people, the study noted. Meanwhile, 16 percent were diagnosed with a new eye condition and 31 percent had a change in their ongoing care, researchers found. The study included data on nearly 6,400 patients who visited a university eye clinic over ... Read more

Related support groups: Eye Conditions, Glaucoma, Cataract, Macular Degeneration, Glaucoma (Open Angle), Uveitis, Iritis, Keratitis, Optic Nerve Disorder, Ocular Herpes Simplex, Retinal Disorders, Macular Edema, Corneal Ulcer, Corneal Abrasion, Glaucoma/Intraocular Hypertension, Diagnosis and Investigation, Chorioretinitis, Strabismus, Glaucoma (Narrow Angle), Visual Defect/Disturbance

Could 'Zaps' to the Brain Help Fight Glaucoma?

Posted 3 Jul 2016 by Drugs.com

FRIDAY, July 1, 2016 – Electrical pulses to the brain may help restore vision in some partially blind patients, German researchers report. Glaucoma and other types of damage to the eye's optic nerve typically cause permanent damage. But, the new technique appears to kick-start the brain's visual control centers, the researchers explained. A 10-day treatment regimen – entailing upwards of nearly an hour a day of electrical pulses aimed directly into the eye – improved vision among patients who were losing their sight, the researchers said. "By giving currents through the eye, we force retinal cells connected to the brain to fire intensely," explained study author Dr. Bernhard Sabel, a member of the medical faculty at the Otto-von-Guericke University of Magdeburg. "This activates the brain's [vision] cells to function better again. And, 'what fires together, wires together.' " ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Diagnosis and Investigation, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Health Tip: Are You Losing Your Vision?

Posted 16 Jun 2016 by Drugs.com

-- Some age-related vision loss is common. But because it tends to happen gradually, you may not be aware that your sight is ebbing. The American Academy of Family Physicians mentions these signs of worsening vision: Difficulty reading your mail, or paying your bills. Trouble seeing the television. Problems signing your name. Having a hard time seeing well enough to walk up and down stairs. Squinting frequently. Read more

Related support groups: Eye Conditions, Glaucoma, Cataract, Glaucoma (Open Angle), Visual Defect/Disturbance, Myopia, Glaucoma (Narrow Angle), Color Vision Defect (Acquired)

25 Million Americans Will Struggle With Vision Problems by 2050

Posted 19 May 2016 by Drugs.com

THURSDAY, May 19, 2016 – As baby boomers age, the number of Americans with vision problems and blindness is expected to double over the next three decades, a new study suggests. In 2015, slightly more than 12 million Americans had a vision problem. But by 2050, that number will rise to 25 million, the researchers predicted. "This study gives us a GPS for our nation's future eye health," said lead researcher Dr. Rohit Varma, a professor of ophthalmology at the University of Southern California Keck School of Medicine in Los Angeles. "Our group and others have shown in previous studies that those who suffer from vision loss not only have a decreased quality of life but can also experience both physical and mental health decline, including an increased risk for chronic health conditions such as diabetes, depression and even death," he said. The economic burden from vision loss and eye ... Read more

Related support groups: Glaucoma, Cataract, Macular Degeneration, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Visual Defect/Disturbance, Glaucoma with Pupillary Block, Aphakia, Pseudophakia

Health Tip: Putting Medicine in Your Eyes

Posted 16 Feb 2016 by Drugs.com

-- You may be wary about applying those new eyedrops prescribed by your doctor. The Cleveland Clinic recommends: Use warm water and soap to wash your hands, then dry with a clean towel. Either grab a mirror or lie down before applying the medicine. Look up at the ceiling, then use one hand to pull down the lower eyelid. Hold the medicine in your other hand, resting on your forehead if needed. Without letting the tip of the bottle or tube touch the eye, gently place the medicine inside your lower eyelid. Then close your eye. If you are taking both an ointment and an eye drop, put the eye drop in first. Wait about five minutes before applying the ointment. Read more

Related support groups: Eye Conditions, Glaucoma, Eye Dryness/Redness, Macular Degeneration, Glaucoma (Open Angle), Conjunctivitis, Conjunctivitis - Bacterial, Blepharitis, Keratitis, Corneal Ulcer, Corneal Abrasion, Ocular Herpes Simplex, Glaucoma/Intraocular Hypertension, Eye Redness/Itching, Conjunctivitis - Allergic, Seasonal Allergic Conjunctivitis, Blepharoconjunctivitis, Glaucoma (Narrow Angle), Herpes Simplex Dendritic Keratitis, Glaucoma with Pupillary Block

Green, Leafy Vegetables Each Day May Help Keep Glaucoma at Bay

Posted 14 Jan 2016 by Drugs.com

THURSDAY, Jan. 14, 2016 – Eating green leafy vegetables daily may decrease the risk of glaucoma – a serious eye disease – by 20 percent or more over many years, a new study suggests. "We found those consuming the most green leafy vegetables had a 20 to 30 percent lower risk of glaucoma," said study leader Jae Kang. Kang is an assistant professor of medicine at Brigham and Women's Hospital and Harvard Medical School in Boston. Glaucoma is an eye condition that usually develops when fluid increases in the front part of the eye and causes pressure, damaging the optic nerve. It can lead to loss of vision, according to the U.S. National Eye Institute. Although the study found an association between eating more leafy greens and a lower risk of glaucoma, it didn't prove cause-and-effect. Kang's team followed nearly 64,000 participants in the Nurses' Health Study from 1984 through 2012, and ... Read more

Related support groups: Eye Conditions, Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Scientists Spot Three More Genes Linked to Glaucoma Risk

Posted 11 Jan 2016 by Drugs.com

MONDAY, Jan. 11, 2016 – The discovery of three more genes linked to the most common type of glaucoma could boost efforts to fight the eye disease, researchers report. The three newly identified genes associated with primary open angle glaucoma bring the total number of such genes to 15, according to the study published online Jan. 11 in Nature Genetics. "Just in time for Glaucoma Awareness Month (January), this unprecedented analysis provides the most comprehensive genetic profile of glaucoma to date," Dr. Paul Sieving, director of the U.S. National Eye Institute (NEI), said in an institute news release. "These findings open avenues for the pursuit of new strategies to screen for, prevent and treat glaucoma," he added. Glaucoma is the most common cause of irreversible vision loss, and it affects 60 million people worldwide and about 2.7 million Americans. The disease causes vision loss ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Glaucoma Patients Have False Notions of Pot's Ability to Treat Their Disease: Survey

Posted 23 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 23, 2015 – Glaucoma patients ask for marijuana prescriptions because they have false notions of its effectiveness in treating the eye disease, a new survey has found. And the trend toward legalization of marijuana has lent additional weight to those misconceptions, the results suggested. Recent research has shown that prescription eye drops are much more effective than marijuana in treating glaucoma, an eye disease that afflicts more than 2 million Americans, said survey author Dr. David Belyea. He is director of glaucoma services at the George Washington University School of Medicine & Health Sciences, in Washington, D.C. Eye doctors need to step up their education efforts and make sure that people understand that marijuana is an impractical option, Belyea and colleagues conclude in their report, which is published Dec. 23 in the journal JAMA Ophthalmology. Glaucoma ... Read more

Related support groups: Eye Conditions, Glaucoma, Glaucoma (Open Angle), Cannabis, Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle)

Lupin Receives FDA Approval for Generic Lumigan Ophthalmic Solution 0.03%

Posted 23 Feb 2015 by Drugs.com

Mumbai, India and Baltimore, Maryland – February 23, 2015: Pharma Major Lupin Limited (Lupin) announced today that it has received final approval for its Bimatoprost Ophthalmic Solution, 0.03% from the United States Food and Drugs Administration (FDA) to market a generic version of Allergan Inc.'s Lumigan Ophthalmic Solution, 0.03%. Lupin Pharmaceuticals Inc. (LPI), the company's U.S. subsidiary would commence marketing the product shortly. Lupin's Bimatoprost Ophthalmic Solution, 0.03% is the AT rated generic equivalent of Lumigan Ophthalmic Solution, 0.03% and is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. Lupin's Bimatoprost Ophthalmic Solution, 0.03% filing was made from its Indore facility which was audited in January, 2015. Two Lupin facilities, the Lupin Bioresearch Center, Pune (LBC) and its ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Lumigan, Glaucoma/Intraocular Hypertension, Bimatoprost

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Glaucoma

Related Drug Support Groups

latanoprost, Lumigan, Xalatan, Travatan, Alphagan, Travatan Z, Cosopt, Azopt, dorzolamide, view more... brimonidine, Alphagan P, Zioptan, Timoptic, travoprost, Rescula, Simbrinza, levobunolol, dorzolamide / timolol, Trusopt, brinzolamide, Betagan, Betoptic, Timoptic Ocudose, Betoptic-S, bimatoprost, Pilopine-HS, Propine, Cosopt PF, tafluprost, dipivefrin, AK-Beta, Betaxon, Piloptic-6, Ocupress, Izba, Betimol, Timoptic-XE, Epinal, Eppy / N, Epifrin, Glaucon, Betagan C-Cap, Piloptic-4, AK-Pro, levobetaxolol, metipranolol, unoprostone, brimonidine / brinzolamide, OptiPranolol, Isopto Carpine, Pilocar, Istalol, Adsorbocarpine, Piloptic-3, Pilagan with C Cap, Ocu-Carpine, Ocusert, Piloptic-1 / 2, Pilostat, Piloptic-1, Akarpine, Piloptic-2, Qoliana